Published in Interact Cardiovasc Thorac Surg on February 20, 2012
Surgical Management of Aorto-Esophageal Fistula as a Late Complication after Graft Replacement for Acute Aortic Dissection. Korean J Thorac Cardiovasc Surg (2016) 0.75
Management of aorto-esophageal fistula secondary after thoracic endovascular aortic repair: a review of literature. Clin J Gastroenterol (2017) 0.75
Aortoesophageal fistula: a comprehensive review of the literature. Am J Med (1991) 2.19
Acute management of aortobronchial and aortoesophageal fistulas using thoracic endovascular aortic repair. J Vasc Surg (2009) 2.02
Surgical management of primary aortoesophageal fistula secondary to thoracic aneurysm. Ann Thorac Surg (2000) 2.01
Aortoesophageal fistula after thoracic aortic stent-graft placement: a rare but catastrophic complication of a novel emerging technique. JACC Cardiovasc Interv (2009) 1.94
Aortoesophageal fistula-relief of massive hematemesis with an endovascular stent-graft. Eur J Radiol (2000) 1.30
In situ aortic allograft insertion to repair a primary aortoesophageal fistula due to thoracic aortic aneurysm. J Vasc Surg (2005) 1.24
Aorto-oesophageal and aortobronchial fistulae following thoracic endovascular aortic repair: a national survey. Eur J Vasc Endovasc Surg (2010) 1.20
Aortoesophageal fistula: an uncommon complication after stent-graft repair of an aortic thoracic aneurysm. Interact Cardiovasc Thorac Surg (2009) 1.07
Primary aortoesophageal fistula from aortic aneurysm: successful surgical treatment by use of omental pedicle graft. J Vasc Surg (1990) 1.07
Successful one-stage operation of aortoesophageal fistula from thoracic aneurysm using a rifampicin-soaked synthetic graft. Interact Cardiovasc Thorac Surg (2007) 1.04
Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections. J Vasc Surg (2010) 1.01
In situ repair of aortobronchial, aortoesophageal, and aortoenteric fistulae with cryopreserved aortic homografts. J Vasc Surg (1997) 0.89
Successful management of esophagoparaprosthetic fistula after aortic surgery. Ann Thorac Surg (2008) 0.88
Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model. J Thorac Cardiovasc Surg (2008) 0.81
Complete coverage of in situ aortograft by total omental pedicle flap as the most reliable treatment of aortoesophageal fistula. Am J Surg (2006) 0.80
Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg (2012) 2.39
Toward quality improvement of thoracic aortic surgery: estimating volume-outcome effect from nationwide survey. Eur J Cardiothorac Surg (2009) 2.15
Effect of procedural volume on outcome of coronary artery bypass graft surgery in Japan: implication toward public reporting and minimal volume standards. J Thorac Cardiovasc Surg (2008) 2.13
Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease. Circ J (2010) 2.08
Age-specific risk stratification in 13488 isolated coronary artery bypass grafting procedures. Interact Cardiovasc Thorac Surg (2011) 2.05
Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J (2010) 1.91
Homozygosity haplotype allows a genomewide search for the autosomal segments shared among patients. Am J Hum Genet (2007) 1.76
Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis. Ann Thorac Surg (2007) 1.69
Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol (2003) 1.67
Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65
One orifice vein reconstruction in left liver plus caudate lobe grafts. Transplantation (2007) 1.57
Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J (2012) 1.56
Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J (2014) 1.51
Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J (2012) 1.51
Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Circ J (2014) 1.50
Japanese guidance for ventricular assist devices/total artificial hearts. Artif Organs (2010) 1.49
Coronary artery bypass grafting in hemodialysis-dependent patients: analysis of Japan Adult Cardiovascular Surgery Database. Circ J (2012) 1.49
Brain protection during ascending aortic repair for Stanford type A acute aortic dissection surgery. Nationwide analysis in Japan. Circ J (2014) 1.47
Advantage of Pulsatility in Left Ventricular Reverse Remodeling and Aortic Insufficiency Prevention During Left Ventricular Assist Device Treatment. Circ J (2015) 1.46
Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device. Circ J (2012) 1.46
Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J (2010) 1.44
Protection from postischemic spinal cord injury by perfusion cooling of the epidural space during most or all of a descending thoracic or thoracoabdominal aneurysm repair. Gen Thorac Cardiovasc Surg (2010) 1.42
Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device. Circ J (2014) 1.40
Enhanced perigraft angiogenesis prevents prosthetic graft infection. Ann Thorac Surg (2008) 1.40
Prevalence of vitreous hemorrhage following coronary revascularization in patients with diabetic retinopathy. Circ J (2010) 1.40
Management of intracranial hemorrhage in a child with a left ventricular assist device. Pediatr Transplant (2012) 1.38
Erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest: an experimental study in a canine model. J Thorac Cardiovasc Surg (2006) 1.38
Anxiety and depression after thoracic aortic surgery or coronary artery bypass. Asian Cardiovasc Thorac Ann (2013) 1.38
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res (2003) 1.37
New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device. J Cardiol (2012) 1.35
Retracted Ventricular afterload and ventricular work in fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with blalock-taussig shunts. Circulation (2002) 1.32
Management of infected grafts and aneurysms of the aorta. Ann Vasc Surg (2005) 1.30
Giant tumorous lesions (correction of legions) surrounding the right coronary artery associated with immunoglobulin-G4-related systemic disease. Cardiology (2011) 1.29
Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol (2005) 1.22
Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J (2011) 1.19
Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis. Cardiology (2009) 1.18
The results of total arch graft implantation with open stent-graft placement for type A aortic dissection. J Thorac Cardiovasc Surg (2002) 1.12
Successful treatment of primary cardiac angiosarcoma with docetaxel and radiotherapy. Angiology (2008) 1.10
Performance of in-hospital mortality prediction models for acute hospitalization: hospital standardized mortality ratio in Japan. BMC Health Serv Res (2008) 1.09
Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol (2006) 1.08
Therapeutic strategy for treating aortoesophageal fistulas. Gen Thorac Cardiovasc Surg (2014) 1.08
Challenges and prospects of a clinical database linked to the board certification system. Surg Today (2014) 1.07
Retracted Arterial hemodynamics in patients after Kawasaki disease. Circulation (2005) 1.06
High-dose carvedilol therapy for mechanical circulatory assisted patients. J Artif Organs (2010) 1.04
The helical flow pump with a hydrodynamic levitation impeller. J Artif Organs (2012) 1.04
Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. Circ J (2015) 1.02
Vacuum-assisted closure with Safetac technology for mediastinitis in patients with a ventricular assist device. J Artif Organs (2010) 1.01
Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology (2006) 1.00
What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model. J Artif Organs (2011) 1.00
Thoracoscopic removal of a papillary fibroelastoma in the left ventricular apex. Interact Cardiovasc Thorac Surg (2006) 0.99
Negative pressure wound therapy for left ventricular assist device-related mediastinitis: two case reports. J Artif Organs (2011) 0.99
Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs (2005) 0.98
Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg (2013) 0.98
Five-week use of a monopivot centrifugal blood pump as a right ventricular assist device in severe dilated cardiomyopathy. J Artif Organs (2013) 0.98
Ductal carcinoma in situ arising in tubular adenoma of the breast. Breast Cancer (2012) 0.97
Alteration of LV end-diastolic volume by controlling the power of the continuous-flow LVAD, so it is synchronized with cardiac beat: development of a native heart load control system (NHLCS). J Artif Organs (2011) 0.97
Successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy. J Artif Organs (2005) 0.96
A novel protocol of retrograde cerebral perfusion with intermittent pressure augmentation for brain protection. J Thorac Cardiovasc Surg (2005) 0.96
Prolonged biventricular assist device support as a bridge to heart transplantation. J Artif Organs (2011) 0.96
Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients. Int Heart J (2015) 0.95